Aeglea BioTherapeutics
therapeutic approach to improve survival in preclinical model of | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
August 2020
Slide
21 of 28
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
June 2020
therapeutic approach to improve survival in preclinical model of | Aeglea BioTherapeutics
Related slides by other companies
Larimar Therapeutics
Investor Presentation
November 2023
extends survival in deficient mice | Larimar Therapeutics
Avenue Therapeutics
IPO
October 2022
preclinical in studies demonstrate efficacy in multiple epilepsy models | Avenue Therapeutics
Chimerix
Results
March 2022
collaboration with employed a preclinical model | Chimerix
Boundless Bio
IPO
March 2024
boundless was formed to deliver a new therapeutic approach for patients with amplified cancers by targeting the underlying biology mise boundless founded series a series series | Boundless Bio
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io